Oral non-benzodiazepine muscle-relaxants for people with acute and chronic primary low back pain: a systematic review with meta-analysis
European Spine Journal · 2025-06 · 34 (6) · 2347-2366
DOI: 10.1007/s00586-025-08786-0 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Spine Journal, online erschienen am 05.04.2025. Verfasst von Andrea Manca und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Sassari, Sassari, Italy. andmanca@uniss.it. Hauptthemen laut MEDLINE: Acute Pain, Chronic Pain, Low Back Pain, Neuromuscular Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Sassari.
Abstract (Originalsprache)
Purpose
To determine benefits and adverse effects (AE) of oral muscle-relaxants (MR) (non-benzodiazepines) for acute (< 6 weeks) and chronic (> 12 weeks) primary LBP, administered alone or combined with analgesics/NSAIDs.
Methods
CENTRAL, MEDLINE, EMBASE, CINAHL were searched for pertinent randomized controlled trials. Primary outcomes comprised lack of pain relief, global efficacy and AE at 5–7 days follow-up assessed dichotomously (risk ratio, RR).
Results
Fifty studies (7531 participants) were included, with data from 4775 pooled in meta-analyses. For acute LBP, non-benzodiazepine MR were associated with increased likelihood of pain relief (moderate certainty; RR: 0.53, p < 0.0001), global efficacy (RR: 0.49, p = 0.0001), muscle spasm (RR: 0.62, p < 0.00001), and physical outcomes (RR: 0.60, p < 0.00001) compared to placebo. AE were more frequent with non-benzodiazepine MR compared to placebo (low-to-moderate certainty; RR: 1.56; p = 0.003), and at central nervous system (CNS; RR: 2.40; p < 0.00001), but not at gastrointestinal (GI) level (RR: 0.77; p = 0.62). Combined non-benzodiazepines + analgesics/non-steroidal anti-inflammatory drugs (NSAIDs) provide a larger and clinically meaningful benefit compared to placebo + analgesics/NSAIDs for global efficacy at 5–7 days (low-certainty; RR: 0.62; p = 0.01). Combined therapy did not result in significant between-group differences for total AE (moderate-certainty; RR: 1.15; p = 0.50) and GI AE (RR: 0.63; p = 0.08), despite responsible for more CNS AE (low-certainty; RR: 1.91; p = 0.002). When comparing non-benzodiazepine MR versus placebo for chronic LBP, only data on total AE could be pooled, without between-group difference (RR: 0.93; p = 0.69).
Conclusions
Non-benzodiazepine MR for acute LBP were associated with increased likelihood of pain relief and global efficacy compared to placebo. Combined therapy with analgesics/NSAIDs proved superior for global efficacy. Studies are needed to evaluate if non-benzodiazepine MR are of larger benefit than analgesics/NSAIDs, and if stand-alone administration provides more benefit than combined treatment. The observed AE warrant caution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy. andmanca@uniss.it.
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
- Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, Vrije Universiteit, Amsterdam, Netherlands.
- Department of Medicine, University of Toronto, Toronto, ON, Canada.
- Surgery Unit, Lenval University Childrens Hospital, Nice, France.
- Department of Surgical Sciences, University of Cagliari, Cagliari, Italy.
Förderung
- Università degli Studi di Sassari
Zitieren
APA
Manca, A., Cugusi, L., van Tulder, M., Furlan, A., Solla, F., & Monticone, M. (2025). Oral non-benzodiazepine muscle-relaxants for people with acute and chronic primary low back pain: a systematic review with meta-analysis. European Spine Journal, 34(6), 2347-2366. https://doi.org/10.1007/s00586-025-08786-0
Vancouver
Manca A, Cugusi L, van Tulder M, Furlan A, Solla F, Monticone M. Oral non-benzodiazepine muscle-relaxants for people with acute and chronic primary low back pain: a systematic review with meta-analysis. European Spine Journal. 2025;34(6):2347-2366. doi:10.1007/s00586-025-08786-0
BibTeX
@article{Manca2025,
author = {Manca, Andrea and Cugusi, Lucia and van Tulder, Maurits and Furlan, Andrea and Solla, Federico and Monticone, Marco},
title = {Oral non-benzodiazepine muscle-relaxants for people with acute and chronic primary low back pain: a systematic review with meta-analysis},
journal = {European Spine Journal},
year = {2025},
volume = {34},
number = {6},
pages = {2347--2366},
doi = {10.1007/s00586-025-08786-0}
}
EUVIMED